Why is Middle East Healthcare Co. ?
1
Poor Management Efficiency with a low ROCE of 6.40%
- The company has been able to generate a Return on Capital Employed (avg) of 6.40% signifying low profitability per unit of total capital (equity and debt)
2
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 12.24% and Operating profit at 24.52% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 9.64% signifying low profitability per unit of shareholders funds
3
Underperformed the market in the last 1 year
- Even though the market (Saudi Arabia All Share TASI) generated negative returns of -11.13% in the last 1 year, its fall in the stock was much higher with a return of -58.96%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Middle East Healthcare Co. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Middle East Healthcare Co.
-58.18%
-1.70
34.84%
Saudi Arabia All Share TASI
-11.13%
-0.71
15.65%
Quality key factors
Factor
Value
Sales Growth (5y)
12.24%
EBIT Growth (5y)
24.52%
EBIT to Interest (avg)
2.16
Debt to EBITDA (avg)
5.81
Net Debt to Equity (avg)
1.14
Sales to Capital Employed (avg)
0.69
Tax Ratio
5.79%
Dividend Payout Ratio
16.32%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.40%
ROE (avg)
9.64%
Valuation Key Factors 
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
2.82
EV to EBIT
17.16
EV to EBITDA
11.17
EV to Capital Employed
1.80
EV to Sales
2.46
PEG Ratio
0.13
Dividend Yield
0.91%
ROCE (Latest)
10.47%
ROE (Latest)
22.06%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
6What is working for the Company
OPERATING CASH FLOW(Y)
Highest at SAR 507.91 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 18.25 times
DEBTORS TURNOVER RATIO(HY)
Highest at 1.57 times
-6What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 8.13% (YoY
OPERATING PROFIT(Q)
Lowest at SAR 150.25 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 19.54 %
PRE-TAX PROFIT(Q)
Lowest at SAR 47.92 MM
NET PROFIT(Q)
Lowest at SAR 35.23 MM
EPS(Q)
Lowest at SAR 0.44
Here's what is working for Middle East Healthcare Co.
Operating Cash Flow
Highest at SAR 507.91 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (SAR MM)
Inventory Turnover Ratio
Highest at 18.25 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 1.57 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Depreciation
Highest at SAR 62.81 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (SAR MM)
Here's what is not working for Middle East Healthcare Co.
Operating Profit
Lowest at SAR 150.25 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (SAR MM)
Operating Profit Margin
Lowest at 19.54 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at SAR 47.92 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (SAR MM)
Net Profit
Lowest at SAR 35.23 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (SAR MM)
EPS
Lowest at SAR 0.44
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (SAR)
Raw Material Cost
Grown by 8.13% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






